@article{ajmcr2017565,
author={{Henn, Nicoli Taiana and Pastorello, Julia and Bueno, Marina Ractz},
title={Severe Pneumonitis in Patient with Kidney Cancer Using Nivolumab after Influenza Vaccine - A Case Report},
journal={American Journal of Medical Case Reports},
volume={5},
number={6},
pages={151--155},
year={2017},
url={http://pubs.sciepub.com/ajmcr/5/6/5},
issn={2374-216X},
abstract={Immunotherapies are new drugs that are revolutionizing the treatment of many malignancies, among them, the kidney cancer. Because of their mechanism of action they can trigger an important inflammatory responses and immune-mediated adverse events. The safety of influenza vaccination during the use of checkpoint inhibitors is not defined. We report the case of a patient with kidney cancer who evolved unfavorably a few days after receiving the influenza immunization without the consent of the oncology specialists.},
doi={10.12691/ajmcr-5-6-5}
publisher={Science and Education Publishing}
}